Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.

Oh JJ, Byun SS, Lee SE, Hong SK, Jeong CW, Choi WS, Kim D, Kim HJ, Myung SC.

Prostate Cancer Prostatic Dis. 2014 Jun;17(2):149-56. doi: 10.1038/pcan.2014.1. Epub 2014 Feb 4.

PMID:
24492489
2.

Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.

Oh JJ, Byun SS, Lee SE, Hong SK, Jeong CW, Kim D, Kim HJ, Myung SC.

Gene. 2014 Jan 1;533(1):86-93. doi: 10.1016/j.gene.2013.09.119. Epub 2013 Oct 9.

PMID:
24120391
3.

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.

Holick CN, Stanford JL, Kwon EM, Ostrander EA, Nejentsev S, Peters U.

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1990-9.

4.

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Zheng SL, Sun J, Cheng Y, Li G, Hsu FC, Zhu Y, Chang BL, Liu W, Kim JW, Turner AR, Gielzak M, Yan G, Isaacs SD, Wiley KE, Sauvageot J, Chen HS, Gurganus R, Mangold LA, Trock BJ, Gronberg H, Duggan D, Carpten JD, Partin AW, Walsh PC, Xu J, Isaacs WB.

J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. Epub 2007 Oct 9.

5.

Variants in the HEPSIN gene are associated with susceptibility to prostate cancer.

Kim HJ, Han JH, Chang IH, Kim W, Myung SC.

Prostate Cancer Prostatic Dis. 2012 Dec;15(4):353-8. doi: 10.1038/pcan.2012.17. Epub 2012 Jun 5.

PMID:
22665141
6.

Replication of prostate cancer risk loci in a Japanese case-control association study.

Yamada H, Penney KL, Takahashi H, Katoh T, Yamano Y, Yamakado M, Kimura T, Kuruma H, Kamata Y, Egawa S, Freedman ML.

J Natl Cancer Inst. 2009 Oct 7;101(19):1330-6. doi: 10.1093/jnci/djp287. Epub 2009 Sep 2.

7.

Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs.

Jiang H, Liu F, Wang Z, Na R, Zhang L, Wu Y, Zheng J, Lin X, Jiang D, Sun J, Zheng SL, Ding Q, Xu J.

Prostate. 2013 Nov;73(15):1651-9. doi: 10.1002/pros.22661. Epub 2013 Jul 18.

8.

The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients.

He Y, Gu J, Strom S, Logothetis CJ, Kim J, Wu X.

Clin Cancer Res. 2014 Oct 1;20(19):5133-9. doi: 10.1158/1078-0432.CCR-14-0661. Erratum in: Clin Cancer Res. 2015 Oct 1;21(19):4496.

9.

Association between single nucleotide polymorphisms on chromosome 17q and the risk of prostate cancer in a Chinese population.

Zhou CH, Wang JY, Cao SY, Shi XH, Zhang YG, Liu M, Wang X, Huang J, Yang YG, Wei D, Yang Z.

Chin J Cancer. 2011 Oct;30(10):721-30. doi: 10.5732/cjc.011.10070.

10.
11.

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.

Mondul AM, Shui IM, Yu K, Travis RC, Stevens VL, Campa D, Schumacher FR, Ziegler RG, Bueno-de-Mesquita HB, Berndt S, Crawford ED, Gapstur SM, Gaziano JM, Giovannucci E, Haiman CA, Henderson BE, Hunter DJ, Johansson M, Key TJ, Le Marchand L, Lindström S, McCullough ML, Navarro C, Overvad K, Palli D, Purdue M, Stampfer MJ, Weinstein SJ, Willett WC, Yeager M, Chanock SJ, Trichopoulos D, Kolonel LN, Kraft P, Albanes D.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):688-96. doi: 10.1158/1055-9965.EPI-13-0007-T. Epub 2013 Feb 1.

12.

Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.

Penney KL, Schumacher FR, Kraft P, Mucci LA, Sesso HD, Ma J, Niu Y, Cheong JK, Hunter DJ, Stampfer MJ, Hsu SI.

Carcinogenesis. 2011 Jun;32(6):853-9. doi: 10.1093/carcin/bgr050. Epub 2011 Mar 18.

13.

Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.

Gilbert R, Bonilla C, Metcalfe C, Lewis S, Evans DM, Fraser WD, Kemp JP, Donovan JL, Hamdy FC, Neal DE, Lane JA, Smith GD, Lathrop M, Martin RM.

Cancer Causes Control. 2015 Feb;26(2):205-18. doi: 10.1007/s10552-014-0500-5. Epub 2014 Dec 9.

14.

Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.

Han JH, Lee YS, Kim HJ, Lee SY, Myung SC.

Asian J Androl. 2015 Mar-Apr;17(2):285-91. doi: 10.4103/1008-682X.133320.

15.

Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.

Batra J, Lose F, O'Mara T, Marquart L, Stephens C, Alexander K, Srinivasan S, Eeles RA, Easton DF, Al Olama AA, Kote-Jarai Z, Guy M, Muir K, Lophatananon A, Rahman AA, Neal DE, Hamdy FC, Donovan JL, Chambers S, Gardiner RA, Aitken J, Yaxley J, Kedda MA, Clements JA, Spurdle AB.

PLoS One. 2011;6(11):e26527. doi: 10.1371/journal.pone.0026527. Epub 2011 Nov 23.

16.

Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.

Shui IM, Mucci LA, Kraft P, Tamimi RM, Lindstrom S, Penney KL, Nimptsch K, Hollis BW, Dupre N, Platz EA, Stampfer MJ, Giovannucci E.

J Natl Cancer Inst. 2012 May 2;104(9):690-9. doi: 10.1093/jnci/djs189. Epub 2012 Apr 12.

17.

The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.

Choi SY, Kim HJ, Cheong HS, Myung SC.

Korean J Urol. 2015 Jan;56(1):19-30. doi: 10.4111/kju.2015.56.1.19. Epub 2015 Jan 12.

18.

Association of six susceptibility Loci with prostate cancer in northern chinese men.

Zhang YR, Xu Y, Yang K, Liu M, Wei D, Zhang YG, Shi XH, Wang JY, Yang F, Wang X, Liang SY, Zhao CX, Wang F, Chen X, Sun L, Zhu XQ, Zhu L, Yang YG, Tang L, Jiao HY, Huo ZH, Yang Z.

Asian Pac J Cancer Prev. 2012;13(12):6273-6.

19.

Single nucleotide polymorphisms in DKK3 gene are associated with prostate cancer risk and progression.

Kim MS, Lee HN, Kim HJ, Myung SC.

Int Braz J Urol. 2015 Sep-Oct;41(5):869-97. doi: 10.1590/S1677-5538.IBJU.2014.0041.

20.

Vitamin D pathway gene variants and prostate cancer prognosis.

Holt SK, Kwon EM, Koopmeiners JS, Lin DW, Feng Z, Ostrander EA, Peters U, Stanford JL.

Prostate. 2010 Sep 15;70(13):1448-60. doi: 10.1002/pros.21180.

Items per page

Supplemental Content

Write to the Help Desk